Publication date: December 2026 Source: Human Pathology, Volume 178 Author(s): Nicole I. Avellanet Crespo, James Corines, Jeffrey S. Ross, Michel R. Nasr
TP53 Y220C hotspot mutation in clinically advanced ovarian carcinoma: Frequency and genomic features. // Human Pathology. – URL: https://www.sciencedirect.com/science/article/pii/S0046817726002571?dgcid=rss_sd_all
TP53 Y220C hotspot mutation in clinically advanced ovarian carcinoma: Frequency and genomic features. Human Pathology. https://www.sciencedirect.com/science/article/pii/S0046817726002571?dgcid=rss_sd_all
“TP53 Y220C hotspot mutation in clinically advanced ovarian carcinoma: Frequency and genomic features.” Human Pathology.
@article{article48067,
title = {TP53 Y220C hotspot mutation in clinically advanced ovarian carcinoma: Frequency and genomic features},
journal = {Human Pathology},
url = {https://www.sciencedirect.com/science/article/pii/S0046817726002571?dgcid=rss_sd_all}
}
ABSTRACT High‐dimensional flow cytometry measures immune cells at single‐cell resolution, enabling systematic characterization of cell populations at scale. But harnessing this potential requires seamless interoperability between the...
Abstract The intraneuronal accumulation of amyloid‐β (Aβ) is an early pathogenic event in Alzheimer's disease (AD), initiating a pathological cascade that includes synaptic dysfunction, metabolic deficits, and eventual neuronal loss....